Gastric Cancer Clinical Trials in Kunming
7 recruitingKunming, China
Showing 1–7 of 7 trials
Recruiting
Phase 2
Novel Combinations in Participants With Locally Advanced Unresectable or Metastatic Gastric or Gastroesophageal Junction Adenocarcinoma
Gastric Cancer
AstraZeneca163 enrolled44 locationsNCT05702229
Recruiting
Phase 3
A Phase Ⅲ Study of Rilvegostomig in Combination With Fluoropyrimidine and Trastuzumab Deruxtecan as the First-line Treatment for HER2-positive Gastric Cancer
Gastroesophageal Junction AdenocarcinomaHER2-positive Gastric Cancer
AstraZeneca840 enrolled284 locationsNCT06764875
Recruiting
Phase 3
Sonesitatug Vedotin in Combination With Capecitabine With or Without Rilvegostomig in Participants With Advanced or Metastatic Gastric, Gastroesophageal Junction, or Esophageal Adenocarcinoma Expressing Claudin18.2
Esophageal CancerGastric CancerGastroesophageal Junction Adenocarcinoma
AstraZeneca2,130 enrolled230 locationsNCT07431281
Recruiting
Phase 2
A Study of T-DXd as Monotherapy or in Combination With Anti-cancer Agents in Patients With Selected HER2-expressing Tumors
Advanced Solid Tumors (Excluding Gastric Cancer and Breast Cancer)
AstraZeneca175 enrolled31 locationsNCT06271837
Recruiting
Not Applicable
Study on the Value of Three DWI Scanning Sequences in Staging of Gastric Cancer
Gastric Cancer
Yunnan Cancer Hospital129 enrolled1 locationNCT06735105
Recruiting
AI Prediction of Gastric Cancer Response to Neoadjuvant Chemotherapy
Gastric CancerImagePathology
Chinese Academy of Sciences200 enrolled22 locationsNCT06035250
Recruiting
Prediction of Peritoneal Metastasis for Gastric Cancer Based on Radiomics
Gastric CancerPeritoneal Metastases
Chinese Academy of Sciences400 enrolled13 locationsNCT05722275